12:00 AM
 | 
Aug 12, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

SPI-3608: Phase Ia data

Top-line data from a double-blind, placebo-controlled, dose-escalation, Japanese Phase Ia trial in about 48 healthy volunteers showed that single doses of oral SPI-3608 were...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >